— Why it moved
Why HOWL Stock Spiked and Faded Today — August 21, 2026
Werewolf Therapeutics announced a reverse-style merger and a large private placement that heavily dilutes current equity holders, triggering a brief premarket spike.
What moved HOWL stock
Werewolf Therapeutics, Inc. is a clinical-stage biopharma company developing cancer treatments. The company announced a definitive all-stock merger with Ambros Therapeutics alongside a $150 million private placement. Existing HOWL shareholders will end up owning just 6.8% of the combined entity, making this a major equity dilution event.
The mechanics
The stock gapped up 74.58% before the opening bell on a float of under 48 million shares. Premarket chatter around the headline financing figure drove over 293 million shares in daily volume, blowing past its 30-day average of 2.78 million.
HOWL by the numbers
The alert window
The alert went out at 8:20 AM ET at $0.7528 during premarket. The stock hit its peak of $1.19 just one minute later at 8:21 AM ET, offering a fast 58.1% sellable window before fading.
How HOWL's move ended
Shares drifted after the initial burst, eventually closing at $0.877 for a 16.5% gain over the alert price. The long-term reality of severe dilution and ownership handover overrides the brief morning volatility.
The tell: Headline merger capital often masks heavy dilution that wipes out existing shareholders.